Edoxaban Impurity 152 | CAS 1210348-23-4 - Request Quote
Edoxaban Impurity 152
| SZ CAT No: | SZ-E041189 |
| CAS No | 1210348-23-4 |
| Mol.F. | C14H26N2O4 |
| Mol.Wt. | 286.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Edoxaban Impurity 152 is chemically Ethyl (1R,3S,4R)-4-amino-3-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylate. Edoxaban Impurity 152 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 152 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1210348-23-4
Purchase 1210348-23-4
Order 1210348-23-4
Enquire 1210348-23-4
price of 1210348-23-4
1210348-23-4 Supplier
1210348-23-4 Manufacturer
1210348-23-4 Exporter
buy high quality Edoxaban Impurity 152
Purchase Edoxaban Impurity 152
Edoxaban Impurity 152 suppliers
Edoxaban Impurity 152 manufacturers
Edoxaban Impurity 152 price
Order Edoxaban Impurity 152
Enquire Edoxaban Impurity 152
Edoxaban Impurity 152 cost
Edoxaban Impurity 152 Supplier
Edoxaban Impurity 152 Distributor
Edoxaban Impurity 152 for Method Validation
Edoxaban Reference Standard
Edoxaban Impurity 152 for ANDA Filing
Edoxaban Impurity 152 for Forced Degradation Studies
Edoxaban Impurity 152 Identification Standards
Edoxaban Impurity 152 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.